Enquiries 03 - 8824 9924
Since March 2017, GP’s and specialists across Australia can legally prescribe a range of medicinal cannabis medicines for certain indications, supplied by an approved importer and dispensed via your local pharmacy. Cannahealth is your medical cannabis product and information gateway which links participating pharmacists to product availability throughout Australia.
Each state and territory health authority (i.e.: QLD Health) provides a patient access pathway for cannabis plant medicines via GP’s and approved Authorised Prescribers. Cannahealth is the online service, that consolidates the processing of cannabis medicines between your doctor’s prescription, your local pharmacy and your state or territory Health Ministry.
Medicinal Cannabis is a new medicine, which, as of November 1st 2016, is now regulated by both federal and state legislation in Australia, under the TGA an Health Department. Historically, the cannabis plant was used as a botanic compound in the preparation of tinctures and oils that were dispensed by pharmacists, as a complimentary treatment for a variety of medical indications.
The AIMC – Australian Institute for Medical Cannabis Inc. is a not-for-profit which is collaborating with scientists and medical specialists across Australia, explaining the health effects of cannabis and cannabinoids use. Our team has begun to work with stakeholders and licensed medicinal cannabis researchers, providing an information portal to the current state of evidence and recommendations for research.
The Cannahealth online service is a project of the AIMC, dedicated to providing information for medical physicians about current research and usages of sponsored medicines available now via participating pharmacies. The Cannahealth Online service also provides product disclosure information and consolidation of SAS Sponsor medicinal cannabis products with government agencies.
In preparation for an Australian supply chain of medicinal cannabis products, seed genetics are being prepared for planting using greenhouse systems. Three studies are being consolidated for potential partnering with research institutions including a study of cannabis use for treating PTSD, lowering opioid dependance in Aged Care and neuropathic pain indications. AIMC will endeavour to provide open science data to all our research findings.
worldwide affiliates and clients
research & pilot studies